Loading…
Reporting person on SEC Form 4
Stelios Papadopoulos
Stelios Papadopoulos is Director at Exelixis. OQRO lists 4 transactions filed with the SEC under this name, the latest on May 29, 2026, each linked to the official Form 4.
Director
Disclosures on record
4
Companies involved
2
Disclosure history
ExelixisEXEL
2 disclosures · Nov 2025 – May 2026 · 1 sold
May 27, 20268,367disclosed May 29
DetailsOfficial recordNov 12, 2025Sold~$4.36Mdisclosed Nov 14
DetailsOfficial record- All activity in Exelixis
Ovid TherapeuticsOVID
2 disclosures · Mar 2026 – Apr 2026
Apr 7, 202618Kdisclosed Apr 9
DetailsOfficial recordFeb 26, 202665Kdisclosed Mar 2
DetailsOfficial record- All activity in Ovid Therapeutics
